BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 2627128)

  • 1. A study of various strategies to enhance the cytotoxic activity of 5-fluorouracil/leucovorin in human colorectal cancer cell lines.
    Scheithauer W; Temsch EM
    Anticancer Res; 1989; 9(6):1793-8. PubMed ID: 2627128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Experimental study of biochemical modulation of 5-fluorouracil with l-leucovorin against human esophageal cancer].
    Terashima M; Ikeda K; Kawamura H; Maesawa C; Takiyama I; Yoshinari H; Koeda K; Sato N; Ishida K; Saito K
    Gan To Kagaku Ryoho; 1992 Oct; 19(12):1999-2004. PubMed ID: 1417007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison between CoFactor and Leucovorin activity applied in combination with 5-fluorouracil against two human colon cancer cell lines.
    Bjelogrlić SK; Srdić T; Radulović S
    J BUON; 2007; 12(1):71-6. PubMed ID: 17436405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination cytotoxic effects of cis-diamminedichloroplatinum(II) and 5-fluorouracil with and without leucovorin against human non-small cell lung cancer cell lines.
    Tsai CM; Hsiao SH; Frey CM; Chang KT; Perng RP; Gazdar AF; Kramer BS
    Cancer Res; 1993 Mar; 53(5):1079-84. PubMed ID: 8382553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cytotoxic effects of the combination of a new nitrosourea, fotemustine, combined with 5-fluorouracil and folinic acid depend on the sequence of their administration].
    Fischel JL; Formento P; Berlion M; Berille J; Gioanni J; Bizzari JP; Milano G
    Bull Cancer; 1992; 79(1):81-90. PubMed ID: 1520955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual effects of folinic acid in 5-fluorouracil induced killing of human tumor cell lines in vitro.
    Blomgren H; Edler D; Hallström M; Ragnhammar P
    Anticancer Res; 1996; 16(5A):2713-7. PubMed ID: 8917376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thymidylate synthase level as the main predictive parameter for sensitivity to 5-fluorouracil, but not for folate-based thymidylate synthase inhibitors, in 13 nonselected colon cancer cell lines.
    van Triest B; Pinedo HM; van Hensbergen Y; Smid K; Telleman F; Schoenmakers PS; van der Wilt CL; van Laar JA; Noordhuis P; Jansen G; Peters GJ
    Clin Cancer Res; 1999 Mar; 5(3):643-54. PubMed ID: 10100718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo potentiation of 5-fluorouracil by leucovorin in murine colon carcinoma.
    Nadal JC; Van Groeningen CJ; Pinedo HM; Peters GJ
    Biomed Pharmacother; 1988; 42(6):387-93. PubMed ID: 3064823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Augmentation of chemotherapeutic efficaciousness of UFT by oral l-leucovorin--l-leucovorin factors enhancing cytotoxic activity of 5-fluorouracil].
    Yuasa C; Okabe H; Toko T; Takeda S; Unemi N
    Gan To Kagaku Ryoho; 1995 Nov; 22(13):1927-32. PubMed ID: 7487122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination studies of antifolates with 5-fluorouracil in colon cancer cell lines.
    van der Wilt CL; Kuiper CM; Peters GJ
    Oncol Res; 1999; 11(8):383-91. PubMed ID: 10803742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro evaluation of the anticancer drug modulatory effect of hyaluronidase in human gastrointestinal cell lines.
    Scheithauer W; Temsch EM; Stefenelli T; Lathan B
    Anticancer Res; 1988; 8(3):391-5. PubMed ID: 3389743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Azidothymidine and dipyridamole as biochemical response modifiers: synergism with methotrexate and 5-fluorouracil in human colon and pancreatic carcinoma cells.
    Zhen YS; Taniki T; Weber G
    Oncol Res; 1992; 4(2):73-8. PubMed ID: 1596584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of cytotoxicity with prolonged exposure to fluorouracil in human colon cancer cells.
    Ren Q; Van Groeningen CJ; Hardcastle A; Aherne GW; Geoffroy F; Allegra CJ; Johnston PG; Grem JL
    Oncol Res; 1997; 9(2):77-88. PubMed ID: 9167189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytotoxicity of floxuridine and 5-fluorouracil in human T-lymphoblast leukemia cells: enhancement by leucovorin.
    Mini E; Moroson BA; Bertino JR
    Cancer Treat Rep; 1987 Apr; 71(4):381-9. PubMed ID: 2950995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rationale for treatment design: biochemical modulation of 5-fluorouracil by leucovorin.
    Rustum YM; Cao S; Zhang Z
    Cancer J Sci Am; 1998; 4(1):12-8. PubMed ID: 9467039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Fas-dependent component in 5-fluorouracil/leucovorin-induced cytotoxicity in colon carcinoma cells.
    Tillman DM; Petak I; Houghton JA
    Clin Cancer Res; 1999 Feb; 5(2):425-30. PubMed ID: 10037193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of recombinant methioninase in combination with cisplatin on human colon tumors in nude mice.
    Tan Y; Sun X; Xu M; Tan X; Sasson A; Rashidi B; Han Q; Tan X; Wang X; An Z; Sun FX; Hoffman RM
    Clin Cancer Res; 1999 Aug; 5(8):2157-63. PubMed ID: 10473100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of 5-fluorouracil resistance in human colon tumor cell lines by azidothymidine.
    Findenig G; Mader RM; Fritzer-Szekeres M; Steger GG; Jaeger W; Szekeres T
    Oncol Res; 1996; 8(5):189-96. PubMed ID: 8884811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dihydropyrimidine dehydrogenase: a tumoral target for fluorouracil modulation.
    Fischel JL; Etienne MC; Spector T; Formento P; Renée N; Milano G
    Clin Cancer Res; 1995 Sep; 1(9):991-6. PubMed ID: 9816071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chronotherapy with high dose carboplatin, 5-fluorouracil and leucovorin in advanced colorectal carcinoma].
    Popov I; Jelić S; Radosavljević D; Nikolić-Tomasević A
    Srp Arh Celok Lek; 1998; 126(9-10):355-61. PubMed ID: 9863407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.